- The signing of this MoU underscores a long-term commitment to addressing India’s growing respiratory care needs and sets the stage for transformative improvements in the field
India, 10th October 2024 – Aerogen, an Ireland-based global leader in acute-care aerosol drug delivery, and Indian Association of Respiratory Care (IARC) signed a MoU to enhance respiratory therapy education and improve patient care across India. This strategic collaboration marks an important day in the development of respiratory care and highlights a shared commitment to elevate respiratory services and outcomes for patients nationwide.
The IARC, representing over 500 Respiratory Therapists, provides education and critical care updates both in India and abroad. With a robust advisory board of leading medical experts, IARC supports respiratory care across hospitals, home care, and training programs. On the other hand, Aerogen prioritizes research and development to innovate its product range and set new standards for quality and efficiency in aerosol drug delivery technology.
This partnership combines Aerogen’s expertise with IARC’s network, focusing on education and training programs to upskill respiratory therapists for the evolving needs of critical care in India.
Debabrata Bhowmick, Commercial Director, Aerogen India, emphasized, “This partnership is pivotal in fostering innovation in respiratory care education and enhancing patient outcomes in India. By merging Aerogen’s technology with IARC’s expertise, we are setting new standards in care while empowering healthcare professionals with the tools and knowledge to excel.”
The partnership will leverage Aerogen’s advanced drug delivery systems to ensure higher-quality care in critical settings, improving patient outcomes and respiratory care services across various healthcare facilities in India.
Delighted to announce this MoU with Aerogen, Dr. Harish Mallapura Maheshwarappa, President of IARC, stated, “This partnership marks a significant milestone in our journey to deliver high-quality respiratory care services. Together, we aim to enhance services, improve patient outcomes through evidence-based practices, and promote research and education.”
Besides training, the collaboration also aims to increase awareness of aerosol and respiratory therapies among healthcare professionals and students, contributing to an improved standard of respiratory care across the country. Dr. Sriharsha Tatineni, Vice President IARC said, “This collaboration is a big step forward in raising awareness among respiratory therapists in India. By equipping healthcare professionals with the right knowledge, tools, and best practices, we are confident that this partnership will elevate respiratory care standards across the country.”
“Aligning with Aerogen’s innovative technology lays the foundation for enhanced patient outcomes and more effective therapies, benefiting countless individuals in need of critical respiratory care.” Dr. Saumy Johnson, General Secretary IARC, further added as she emphasized the impact of the collaboration.
Aerogen entered the Indian market in 2019 with the support of Enterprise Ireland, the Irish government organization responsible for promoting Irish enterprises globally. Ross Curran, Director, India & South Asia, Enterprise Ireland, commented, “Aerogen is the partner of choice for the world’s leading ventilator companies for aerosol drug delivery. We are excited to witness this impactful partnership with IARC. Together, Aerogen’s cutting-edge technology and IARC’s deep understanding of the Indian healthcare landscape will significantly advance training and enhance healthcare infrastructure in India.”
The signing of this MoU reflects a long-term commitment to address India’s growing respiratory care needs, setting the stage for transformative improvements in the field. Aerogen and IARC are positioned to make a significant impact on patient lives and the professional development of healthcare providers in India.
About Aerogen:
Headquartered in Galway, Ireland, Aerogen is a global leader in aerosol drug delivery systems, specializing in acute care. The company’s patented vibrating mesh technology converts liquid medications into fine aerosols, enabling efficient delivery to the lungs for critical care patients. With over 25 years of innovation, Aerogen’s technology is trusted in more than 75 countries and has been used to treat over 16 million patients globally. Known for its high-performance devices, such as the Aerogen Solo, the company continues to expand its reach and workforce, with significant investments in research and development. Aerogen plays a crucial role in treating respiratory conditions and continues to advance healthcare solutions worldwide.
To know more about Aerogen, please visit: https://www.aerogen.com/
About IARC
The Indian Association of Respiratory Care (IARC) is an organization for the young and dynamic Respiratory Therapists in and around India. The association functions as an organized voice for Respiratory Therapist in continuing medical education and critical care updates. With more than 500 members nationwide as well as abroad, IARC focuses on respiratory care professionals in hospitals and with home care companies, managers of respiratory and cardiopulmonary services, and educators who provide respiratory care training. The association has a strong advisory board which includes professional and pioneers such as Anaesthesiologists, Pulmonologists, Medicines, Intensivist, Cardiologists and Paediatricians.
To know more about IARC, please visit: https://iarc.in/
About Enterprise Ireland
Enterprise Ireland is the Irish government organization responsible for the development and growth of Irish enterprises in world markets. Enterprise Ireland works in partnership with Irish enterprises to help them start, grow, innovate and win export sales in global markets. In this way, the organization supports sustainable economic growth, regional development and secure employment. A key priority is the achievement of export sales growth and jobs for Irish-owned companies.
To know more about Enterprise Ireland, please visit: https://www.enterprise-ireland.com/en/
